Dishman Carbogen Amcis Limited has informed the Exchange regarding a press release dated October 28, 2021, titled "Announcement: Company s wholly owned subsidiary viz. CARBOGEN AMCIS SAS alongwith NH TherAguix announces the release of a new batch of AGuIX Drug Product for clinical trials ".